NCT06174116: Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia |
|
|
| Recruiting | 4 | 50 | US | Lumateperone, Caplyta, Placebo | University of Massachusetts, Worcester, Intra-Cellular Therapies, Inc. | Schizophrenia, Schizo Affective Disorder | 08/26 | 11/26 | | |
NCT03526354: Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder |
|
|
| Completed | 4 | 52 | US | Brexpiprazole, Study Medication, Treatment as Usual, Current Antipsychotic Treatment | University of Massachusetts, Worcester, Massachusetts General Hospital, University of North Carolina, Chapel Hill, Otsuka Pharmaceutical Co., Ltd., Augusta University | Schizophrenia, Schizoaffective Disorder, Substance Use Disorders | 02/24 | 02/24 | | |
